Wed.May 15, 2024

article thumbnail

Walgreens to Start Selling its Own OTC Naloxone Nasal Spray

Drug Topics

The company’s version of the opioid overdose medication will be $10 cheaper than branded products and is set to be available in stores later this month.

210
210
article thumbnail

Collaboration Is Key When Implementing SDOH Screening Programs

Pharmacy Times

Properly training staff and gaining stakeholder buy-in are crucial steps to successfully designing and launching a program to screen and address health-related social needs.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Reviewing Efficacy, Safety of Weight Loss Therapies in T1D

Drug Topics

Different weight loss therapies provide a wide range of benefits to patients with T1D—but they have some potential adverse effects.

206
206
article thumbnail

FDA Ensures Safety and Effectiveness of Laboratory Developed Tests

Pharmacy Times

Under the modification to the Food, Drug, & Cosmetics Act, individuals and health care providers can hopefully have more confidence in in vitro diagnostic devices.

FDA 144
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

My rendezvous with the raw milk black market: quick, easy, and unchecked by the FDA

STAT

WASHINGTON — It’s Friday May 10, and I’m on my way to what feels like the world’s weirdest drug deal. I received a text the day before from a man named Karl. My order would be arriving from Maryland between 2 and 4 p.m. at the northwest D.C. drop site. It’ll be safely wrapped in ice packs, he assured me.

FDA 144
article thumbnail

Study: Contact With Children Causes Transmission of Pneumococcal Disease Among Older Adults

Pharmacy Times

The prevalence of transmission was higher for those who had contact with children aged less than 5 years and aged 5 to 9 years compared with children aged older than 10.

139
139

More Trending

article thumbnail

Uber Health to roll out new caregiving solution to simplify benefits, logistics for families

Fierce Healthcare

NEW YORK CITY—Uber Health will begin rolling out a new solution designed for caregivers this summer, the company announced at its annual product event Wednesday. | Uber Caregiver will allow care-receivers to add a caregiver to their Uber profile so they can see and spend their health benefits on eligible services, request rides to doctor’s appointments or order groceries.

137
137
article thumbnail

Expansion of OTC Medications: What Does This Mean for Pharmacy?

Pharmacy Times

Student pharmacists are uniquely positioned to support community pharmacists and help educate members of their community and other health care professionals.

137
137
article thumbnail

Senators Whitehouse, Cassidy propose bipartisan primary care payment reform, seek industry feedback

Fierce Healthcare

U.S. | Senators Sheldon Whitehouse and Bill Cassidy want to reform how primary care providers get paid through Medicare, and they also want to hear from the healthcare industry about the best way to do it.

134
134
article thumbnail

Opinion: Cutting-edge insulin is good. But it’s the ‘trailing edge’ of older versions that can keep it affordable

STAT

Physicians Frederick Banting and John MacLeod declined to be listed on the patent for insulin in 1923; their co-inventors Charles Best and James Collip sold the patent to the University of Toronto for $1. But despite the discoverers’ efforts to make insulin available and cheap for everyone, it has today become the poster child for soaring pharmaceutical prices.

127
127
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

House Energy and Commerce Committee presents own 2-year telehealth extension, with more rural health wins

Fierce Healthcare

The Energy and Commerce Committee released telehealth extension legislation today that will be voted on during a health subcommittee markup Thursday. | The House Energy and Commerce health subcommittee will hold a markup May 16 that includes a different two-year telehealth extension proposal than the Ways and Means Committee passed last week.

125
125
article thumbnail

Drug overdose deaths fell for first time in five years, though still exceeded 100,000

STAT

U.S. drug deaths decreased slightly in 2023, according to new data, the first decrease in five years. Last year saw 107,543 U.S. drug overdose deaths, according to preliminary statistics released Wednesday by the Centers for Disease Control and Prevention, roughly a 3% drop from 2022.

126
126
article thumbnail

T1D Prevalence Increased Among US Adults Aged 45 to 64

Drug Topics

Type 1 diabetes (T1D), which once predominantly affected children, is increasingly affecting older adults in the US, with prevalence rates peaking in those aged 45 to 64, according to recent research.

98
article thumbnail

To detect risk of stroke, tiny probe acts ‘like a microscope’ inside brain’s blood vessels

STAT

To better understand problems in the brain’s blood vessels that may lead to stroke, we need a better way to see them. Cardiovascular imaging can peer inside coronary arteries to spot clots blocking blood flow to the heart, but those tools are dangerously large for the smaller arteries inside the brain that twist and turn in tortuous ways. Now researchers have designed a probe minuscule enough to fit inside the microcatheters that surgeons snake into cerebral arteries to place reinforcing

125
125
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

The Flawless Fallacy: A Pharmacist’s Guide to Skin Care in the Digital Age

Drug Topics

Cutting through the noise of social media is key when educating patients on how to make better choices for their skin.

123
123
article thumbnail

STAT+: Galapagos, in makeover mode, strikes deal to make CAR-T therapies at blood centers across U.S.

STAT

Seeking to differentiate itself from other makers of CAR-T cancer therapies, Galapagos NV on Wednesday announced it had struck a deal with Blood Centers of America to open up dozens of manufacturing sites for its cell-based medicines around the U.S. Galapagos said it will rely on the partnership, the financial terms of which were not disclosed, as it moves its CAR-Ts for different cancers into pivotal studies and could also help launch those medicines should they win approval.

Hospitals 116
article thumbnail

Workforce training, emergency response funding top AHA's FY2025 appropriations asks

Fierce Healthcare

As Congress hammers out the federal budget for 2025, the hospital industry’s wish list is headlined by programs to strengthen the healthcare workforce and hospitals’ emergency response capabilities | The hospital lobby called for "bold increases" in Health Resources and Services Administration discretionary funding to address "the workforce crisis facing our nation" in letters this week to congressional appropriations subcommittees.

Hospitals 115
article thumbnail

Continued Tezepelumab Treatment Benefits Patients With Severe, Uncontrolled Asthma

Pharmacy Times

The continuation of tezepelumab showed stronger benefits after stopping treatment for 2 years and compared with placebo.

132
132
article thumbnail

Opinion: Listen: Free medical tuition alone isn’t enough to close gaps in primary care

STAT

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics.

article thumbnail

LogiPharma Europe 2024: World Courier President Talks Mitigating Supply Chain Risks

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno at LogiPharma Europe, Nick Porter, President, World Courier discusses mitigating supply chain risks, the future of artificial intelligence in pharma logistics, and more.

105
105
article thumbnail

STAT+: Pharmalittle: We’re reading about fake studies, AbbVie investing in psychedelics, and more

STAT

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the sobering possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is maple bourbon.

Dosage 108
article thumbnail

FDA approves Roche’s HPV self-collection screening option

Pharmafile

Roche has announced that the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-collection solution. This makes the solution one of the first available in the US, allowing more women to utilise an accessible screening option. The post FDA approves Roche’s HPV self-collection screening option appeared first on Pharmafile.

FDA 105
article thumbnail

UnitedHealth's investments in affordable housing top $1B

Fierce Healthcare

UnitedHealth Group's investments in affordable housing have topped $1 billion, with the program a keystone in its overarching strategy to address health equity and disparities. | UnitedHealth Group's investments in affordable housing have topped $1 billion, with the program a keystone in its overarching strategy to address health equity and disparities.

103
103
article thumbnail

GSK, UK govt put £130m into antimicrobial resistance fight

pharmaphorum

GSK has become the first founding partner of the new Fleming Initiative, which aims to tackle the rising threat of antimicrobial resistance (AMR) and is also backed by the UK government.

101
101
article thumbnail

Abby Boreen: Balancing the worlds of PharmD and professional hockey

Blog: Ask a Student Pharmacist

Abby Boreen: Balancing the worlds of PharmD and professional hockey eomizowh Wed, 05/15/2024 - 11:21 Author: Erin Wilson Photo credit: Bjorn Franke and Brad Rempel PharmD student Abby Boreen took her finals early this semester so that she could catch her flight to Canada for the first playoff game of the Professional Women’s Hockey League, where she’s a forward for Minnesota.

article thumbnail

FDA clears Roche self-collection system for HPV screening

pharmaphorum

The FDA has approved Roche's HPV self-sampling solution that the company says can tackle unequal access to screening that can put women at risk of cervical cancer

FDA 103
article thumbnail

Ensuring sterility of a novel anti-VEGF bispecific antibody

European Pharmaceutical Review

Research has demonstrated a cost-effective storage solution for compounded faricimab kept for a maximum of 28 days. Authors of the paper stated that it provides off-label use of the anti- vascular endothelial growth factor (VEGF)/angiopoietin-2 (Ang-2) biologic , “while maintaining safety in the treatment of patients”. Their study compared the stability, sterility, and binding affinity to VEGF and Ang-2 of faricimab.

article thumbnail

Home testing devices for sleep apnoea backed for NHS use

pharmaphorum

Five home-testing devices to diagnose sleep apnoea, which can affect the health of around 2.5 million adults in the UK, have been recommended for NHS use by NICE.

102
102
article thumbnail

Leqembi gets closer to being offered as an injection

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. A bunch of my colleagues are traveling to San Francisco (without me) for our  Breakthrough West Summit  happening tomorrow. If you have FOMO like me, you can still  register  to get a virtual pass.

FDA 97
article thumbnail

Eisai, Biogen start delayed subcutaneous Leqembi filing

pharmaphorum

Eisai and Biogen have filed a rolling biologics license application in the US for a subcutaneous formulation of Alzheimer’s disease therapy Leqembi that was delayed by the FDA on procedural grounds.

FDA 97
article thumbnail

With new partnership, Galapagos takes decentralized CAR-T manufacturing quest nationwide

Fierce Pharma

Though Galapagos has undergone plenty of staff shakeups and strategy revamps in recent years, the company is sticking strong to the CAR-T pivot first unveiled by CEO Paul Stoffels, M.D., following | Galapagos has teamed up with the largest blood supply network in the U.S. to help establish decentralized CAR-T production on a national scale.

95
article thumbnail

Updated BIOSECURE Act draft clears House committee

pharmaphorum

House Oversight Committee passes BIOSECURE Act, which would restrict US companies from contracting with Chinese biotechs including WuXi AppTec, MGI and BGI

103
103
article thumbnail

STAT+: WuXi Biologics execs register to lobby as Congress comes for the company

STAT

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States. Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee.

article thumbnail

Case Study: MHRA

pharmaphorum

MHRA's innovative regulatory approach enables Nuwiq's accelerated clinical trial timeline for haemophilia patients. Learn how their flexible approach is speeding access to new treatments.

93